← Back to Search

Behavioral Intervention

Electronic Quality of Life Reporting for Post-Pediatric Liver Transplant (SPaRO Trial)

N/A

Waitlist Available

Led By Eyal Shemesh, MD

Research Sponsored by University of Pittsburgh

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 24 months

Awards & highlights

SPaRO Trial Summary

This trial uses a smartphone application/web interface to collect reports of a pediatric liver transplant recipient's quality of life from the child and parent, in order to evaluate how well the application can help integrate these evaluations into care.

Who is the study for?

This trial is for pediatric liver transplant recipients aged over 8 and under 20 years, who had their transplant at least a year ago. They must speak English or Spanish well enough to understand the study and have internet access. It's not for those planning to change medical services within a year.Check my eligibility

What is being tested?

The study tests how well a smartphone app/web interface can collect quality of life reports from kids with liver transplants and their parents. The goal is to see if these reports can help improve care by using the Pediatric Liver Transplant Quality of Life questionnaire.See study design

What are the potential side effects?

Since this trial involves answering questionnaires through an app or web interface, there are no direct physical side effects like you'd expect with medication. However, participants may experience stress or discomfort while reflecting on their quality of life.

SPaRO Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 24 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~24 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Secondary outcome measures

Baseline medication level variability index (MLVI)

Implementation metric

Medication level variability index (MLVI)

+4 more

Other outcome measures

Rejection

SPaRO Trial Design

1Treatment groups

Experimental Treatment

Group I: Pediatric liver transplant recipientsExperimental Treatment1 Intervention

As this is a single arm trial, all eligible liver transplant recipients and their caregivers will be enrolled in this arm. Eligible participants are children who received a liver transplant at least 1 year prior to enrollment at a participating SNEPT center and continue to receive their post-transplant care at that center.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Icahn School of Medicine at Mount SinaiOTHER

858 Previous Clinical Trials

524,084 Total Patients Enrolled

The Hospital for Sick ChildrenOTHER

687 Previous Clinical Trials

6,944,831 Total Patients Enrolled

Emory-Children's CenterOTHER

3 Previous Clinical Trials

5,000,438 Total Patients Enrolled

Media Library

PeLTQL delivery via electronic means (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05241847 — N/A

Quality of Life Clinical Trial 2023: PeLTQL delivery via electronic means Highlights & Side Effects. Trial Name: NCT05241847 — N/A

PeLTQL delivery via electronic means (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05241847 — N/A

Quality of Life Research Study Groups: Pediatric liver transplant recipients

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the age limit for enrollees in this trial set at above 40 years?

"In order to meet the criteria for participation in this medical trial, potential participants must be between 8 and 20 years old."

Answered by AI

How many participants is the research team recruiting for this trial?

"This medical trial necessitates 300 applicants that satisfy the eligibility requirements. These people can take part in this research project from locations such as Emory Children's at Atlanta, Georgia or Columbia University Children's at New york, New York."

Answered by AI

How many healthcare centers in this city are administering the clinical trial?

"Currently, 7 different clinical trial sites are recruiting for this study. These can be found in Atlanta, New york and Toronto just to name a few cities. It is therefore important that participants choose the closest clinic to them reduce any potential travelling burdens associated with their enrollment."

Answered by AI

Am I eligible to take part in this clinical exploration?

"This medical trial seeks 300 volunteers aged 8 to 20 years old with adolescent behaviors. To be eligible, they should have had a liver transplant at least one year before enrollment and must possess the technological capabilities to access the internet as well as English or Spanish fluency sufficient for comprehending study procedures and consent forms."

Answered by AI

Is enrollment for this experiment available at the present time?

"Yes, according to the clinicaltrials.gov listing, this trial is currently recruiting participants. It was initially posted on February 28th 2022 and updated last on October 6th 2022. The study needs 300 patients from 7 participating sites."

Answered by AI

Recent research and studies

The Journal of PediatricsJournal

Development and Validation of the Pediatric Liver Transplantation Quality of Life: A Disease-specific Quality of Life Measure for Pediatric Liver Transplant Recipients

Ng, Vicky, David Nicholas, Anil Dhawan, Nada Yazigi, Looi Ee, Michael Stormon, Susan Gilmour, Rick Schreiber, Rachel Taylor, and Anthony Otley. 2014. “Development and Validation of the Pediatric Liver Transplantation Quality of Life: A Disease-specific Quality of Life Measure for Pediatric Liver Transplant Recipients”. The Journal of Pediatrics. Elsevier BV. doi:10.1016/j.jpeds.2014.05.024.

clinicaltrials.govStudy

Starzl Network Patient Reported Outcomes

George Mazariegos 2022. "Starzl Network Patient Reported Outcomes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05241847.